陳 淑惠

Medicine & Life Sciences

1. Precursor Cell Lymphoblastic Leukemia-Lymphoma 100%
2. Child 58%
3. Granulocyte Colony-Stimulating Factor 57%
4. Fetal Blood 49%
5. Acute Myeloid Leukemia 45%
6. Tissue Donors 39%
7. Bone Marrow 39%
8. Thrombopoietin 38%
9. Leukemia 32%
10. Peripheral Blood Stem Cells 32%
11. Pediatrics 31%
12. Drug Therapy 27%
13. Hematopoietic Stem Cells 27%
14. Neuroblastoma 26%
15. Myelopoiesis 26%
16. Erythropoietin 24%
17. Granulocyte-Macrophage Progenitor Cells 24%
18. Bone Marrow Cells 22%
19. Interleukin-3 22%
20. Erythropoiesis 21%
21. Therapeutics 21%
22. Intravenous Immunoglobulins 20%
23. Cranial Irradiation 20%
24. Cell Count 20%
25. Progression-Free Survival 19%
26. Central Nervous System 18%
27. Blood Banks 18%
28. Leukocyte Count 17%
29. Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16%
30. Erythrocyte Indices 16%
31. Multiplex Polymerase Chain Reaction 16%
32. Neoplasms 15%
33. Recurrence 15%
34. Reverse Transcriptase Polymerase Chain Reaction 14%
35. Imatinib Mesylate 14%
36. Mutation 13%
37. Megakaryocytes 13%
38. Cytarabine 13%
39. Bacteremia 12%
40. Blood Component Removal 12%
41. Erythrocytes 12%
42. Survival 12%
43. Survival Rate 12%
44. Blood Cells 12%
45. B-Lymphocytes 12%
46. Volunteers 11%
47. Stem Cells 11%
48. Transient Myeloproliferative Syndrome 11%
49. folylpolyglutamate synthetase 10%
50. fucoxanthin 10%